![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Aerie Looks for Rhopressa NDA in Q3 (OIS: Ophthalmology Innovation Source) View |
![]() |
Clinical Progress of Aerie Pharmaceuticals’ Rhopressa and Roclatan (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie: Bringing Rhopressa and Roclatan into US glaucoma marke (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Pharmaceuticals: Moving Beyond Glaucoma (OIS@ASRS 2016) (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Pharmaceuticals Using ROCK Inhibitors to Change Glaucoma Management (OIS@AAO 2016) (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie COO Mitro Provides Staffing, Pipeline Update (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Pharmaceuticals - OIS@AAO 2015 (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Plans Next Step after Rhopressa (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Pharmaceuticals - OIS@ASCRS 2015 (OIS: Ophthalmology Innovation Source) View |
![]() |
Aerie Pharmaceuticals Reports Strong Progress in Retinal Program (OIS: Ophthalmology Innovation Source) View |